|
FATE Fate Therapeutics Inc 1434316 |
| Balance Sheet |
|
Current Assets
|
$157,953,000.00 |
|
Assets
|
$260,103,000.00 |
|
Current Liabilities
|
$32,592,000.00 |
|
Equity
|
$153,438,000.00 |
|
Shares Out
|
116694106.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,400,000.00 |
|
Investing Cash Flow
|
$38,144,000.00 |
| Market Analysis |
Market Cap
|
$285,900,559.70 |
|
Price
|
$2.45 |
|
BVPS
|
1.31 |
|
PB
|
1.87 |
|
EPS
|
-0.25 |
|
PS
|
34.33 |
|
FCF
|
$-23,719,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.27 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-13 |
-0.26 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.29 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.27 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FATE documents filed with the SEC.
FATE Filings
Clear
